Taiwan has pioneered rare disease treatment by passing The Rare Disease and Orphan Drug Act in 2000, becoming the first in the world to support both treatment & drug development! This forward-thinking approach has not only attracted global pharma companies but also fueled the rise of 30+ local biotech firms developing orphan drugs. 
What’s Happening Now?

• 6 orphan drugs have already received market approval in Taiwan
• 30+ biotech companies are advancing rare disease drug development
• More orphan drugs are moving into clinical trials & licensing deals

Get a quick update on 10 key players & their latest milestones in just 3 minutes!
Follow #Globalbio for the latest in biotech and pharma!
Read More: https://reurl.cc/Q5rr45
#OrphanDrugs #RareDisease #TaiwanBiotech #ODD #PharmaInnovation #ClinicalTrials